Retatrutide

Experimental triple-action peptide: an agonist of the GLP-1, GIP and GCGR receptors. Preclinical studies investigate it for significant weight loss, improved glucose control and broad metabolic benefits.

• 20 mg: $2,900 MXN
• 30 mg: $3,890 MXN
• 50 mg: $5,490 MXN

Studied benefits

• Significant weight loss
• Improved glucose control
• Reduced appetite
• Increased energy expenditure
• Improved body composition

Research use only.